On Sept. 23, 2021, six chief commercial officers (CCOs) joined Pharmaceutical Executive to discuss the future of sales and marketing in biopharma, a topic that is especially relevant due to the rate of acceleration brought on by the COVID-19 pandemic. While a healthy dose of weary change was already in progress within the industry over the past few years, March 2020 quickly ushered in a new way of fundamentally approaching the world and its stakeholders on all fronts. Panelists shared their insights and visions for delivering innovation and health care solutions in the future, while considering products, informed/empowered patients, healthcare professionals (HCPs), and payers.
The Future of Sales and Marketing: How to Deliver Information in the Era of COVID-19 (pharmexec.com)
